title: Elevated free fatty acids and impaired adiponectin bioactivity contribute to reduced SOD2 protein in monocytes of type 2 diabetes patients.
authors.affiliation: Department of Internal Medicine I, Regensburg University Hospital, D-93042 Regensburg, Germany.
authors.forename: Sabrina
authors.initials: S
authors.lastname: Bauer
authors.forename: Josef
authors.initials: J
authors.lastname: Wanninger
authors.forename: Markus
authors.initials: M
authors.lastname: Neumeier
authors.forename: Sylvia
authors.initials: S
authors.lastname: Wurm
authors.forename: Johanna
authors.initials: J
authors.lastname: Weigert
authors.forename: Andrea
authors.initials: A
authors.lastname: Kopp
authors.forename: Margarita
authors.initials: M
authors.lastname: Bala
authors.forename: Andreas
authors.initials: A
authors.lastname: Schäffler
authors.forename: Charalampos
authors.initials: C
authors.lastname: Aslanidis
authors.forename: Christa
authors.initials: C
authors.lastname: Buechler
mesh_terms: D017667:Adipocytes / Q000378:metabolism; D052242:Adiponectin / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology*; D000328:Adult; D000368:Aged; D015992:Body Mass Index; D016022:Case-Control Studies; D002478:Cells, Cultured; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005230:Fatty Acids, Nonesterified / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009000:Monocytes / Q000187:drug effects* / Q000378:metabolism; D011994:Recombinant Proteins / Q000378:metabolism / Q000494:pharmacology; D013482:Superoxide Dismutase / Q000378:metabolism* / Q000494:pharmacology; D000099156:Superoxide Dismutase 2
chemical_list: D052242:Adiponectin; D005230:Fatty Acids, Nonesterified; D011994:Recombinant Proteins; D013482:Superoxide Dismutase; D000099156:Superoxide Dismutase 2